Literature DB >> 16892363

Design and synthesis of a PSMA inhibitor-doxorubicin conjugate for targeted prostate cancer therapy.

Sarva Jayaprakash1, Xinning Wang, Warren D Heston, Alan P Kozikowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16892363     DOI： 10.1002/cmdc.200500044

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  11 in total

1.  Design, synthesis, and initial biological evaluation of a steroidal anti-estrogen-doxorubicin bioconjugate for targeting estrogen receptor-positive breast cancer cells.

Authors:  Kinh-Luan Dao; Rupa R Sawant; J Adam Hendricks; Victoria Ronga; Vladimir P Torchilin; Robert N Hanson
Journal:  Bioconjug Chem       Date:  2012-04-04       Impact factor: 4.774

Review 2.  GCPII imaging and cancer.

Authors:  C A Foss; R C Mease; S Y Cho; H J Kim; M G Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules.

Authors:  Andrew X Zhang; Ryan P Murelli; Cyril Barinka; Julien Michel; Alexandra Cocleaza; William L Jorgensen; Jacek Lubkowski; David A Spiegel
Journal:  J Am Chem Soc       Date:  2010-09-15       Impact factor: 15.419

4.  Novel Small Molecule Probes for Metastatic Melanoma.

Authors:  Anyanee Kamkaew; Nanyan Fu; Weibo Cai; Kevin Burgess
Journal:  ACS Med Chem Lett       Date:  2016-12-09       Impact factor: 4.345

5.  Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy.

Authors:  Santimukul Santra; Charalambos Kaittanis; Oscar J Santiesteban; J Manuel Perez
Journal:  J Am Chem Soc       Date:  2011-09-27       Impact factor: 15.419

Review 6.  Intracellular delivery of RNA-based therapeutics using aptamers.

Authors:  Kristina W Thiel; Paloma H Giangrande
Journal:  Ther Deliv       Date:  2010-12

Review 7.  Emerging critical role of molecular testing in diagnostic genitourinary pathology.

Authors:  George J Netto; Liang Cheng
Journal:  Arch Pathol Lab Med       Date:  2012-04       Impact factor: 5.534

8.  Tunable pH-Sensitive 2-Carboxybenzyl Phosphoramidate Cleavable Linkers.

Authors:  Brian S Backer; Cindy J Choy; Austen L Davis; Zachery S Browne; Clifford E Berkman
Journal:  Tetrahedron Lett       Date:  2020-01-25       Impact factor: 2.415

9.  Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer.

Authors:  Zheng-Hong Peng; Monika Sima; Mohamed E Salama; Pavla Kopečková; Jindřich Kopeček
Journal:  J Drug Target       Date:  2013-12       Impact factor: 5.121

10.  Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer.

Authors:  Yawen Li; Ming-Kuan Chyan; Donald K Hamlin; Holly Nguyen; Robert Vessella; D Scott Wilbur
Journal:  Nucl Med Biol       Date:  2020-05-03       Impact factor: 2.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.